N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide

C130H203N21O32S9 — CID 173123498

IUPACN-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide
SMILESCC(C)(C(=O)Nc1n[nH]c(-c2ccccc2)n1)S(=O)(=O)C1CCCC1.CC(C)(C(=O)Nc1n[nH]c(-c2ccccc2)n1)S(=O)(=O)CC1CCOCC1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)C2CCOCC2)on1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)CC2CC2)on1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)CC2CCC2)on1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)CC2CCOCC2)on1.CC(C)(C)c1nnc(NC(=O)C(C)(C)S(=O)(=O)C2CCCC2)s1.CC(C)CCS(=O)(=O)C(C)(C)C(=O)Nc1cc(C(C)(C)C)no1
InChIInChI=1S/C18H24N4O4S.C17H22N4O3S.C17H28N2O5S.C16H26N2O5S.C16H26N2O4S.C16H28N2O4S.C15H25N3O3S2.C15H24N2O4S/c1-18(2,27(24,25)12-13-8-10-26-11-9-13)16(23)20-17-19-15(21-22-17)14-6-4-3-5-7-14;1-17(2,25(23,24)13-10-6-7-11-13)15(22)19-16-18-14(20-21-16)12-8-4-3-5-9-12;1-16(2,3)13-10-14(24-19-13)18-15(20)17(4,5)25(21,22)11-12-6-8-23-9-7-12;1-15(2,3)12-10-13(23-18-12)17-14(19)16(4,5)24(20,21)11-6-8-22-9-7-11;1-15(2,3)12-9-13(22-18-12)17-14(19)16(4,5)23(20,21)10-11-7-6-8-11;1-11(2)8-9-23(20,21)16(6,7)14(19)17-13-10-12(18-22-13)15(3,4)5;1-14(2,3)12-17-18-13(22-12)16-11(19)15(4,5)23(20,21)10-8-6-7-9-10;1-14(2,3)11-8-12(21-17-11)16-13(18)15(4,5)22(19,20)9-10-6-7-10/h3-7,13H,8-12H2,1-2H3,(H2,19,20,21,22,23);3-5,8-9,13H,6-7,10-11H2,1-2H3,(H2,18,19,20,21,22);10,12H,6-9,11H2,1-5H3,(H,18,20);10-11H,6-9H2,1-5H3,(H,17,19);9,11H,6-8,10H2,1-5H3,(H,17,19);10-11H,8-9H2,1-7H3,(H,17,19);10H,6-9H2,1-5H3,(H,16,18,19);8,10H,6-7,9H2,1-5H3,(H,16,18)
InChIKeyOAZQMSSRHNWHKA-UHFFFAOYSA-N
MW2860.77 g/mol
LogP20.87
Rot. Bonds40

About N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide

N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide (PubChem CID 173123498) has the molecular formula C130H203N21O32S9 and a molecular weight of 2860.77 g/mol. Its IUPAC name is N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide.

Molecular Properties

Compound NameN-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide
PubChem CID173123498
Molecular FormulaC130H203N21O32S9
Molecular Weight2860.77 g/mol
Exact Mass2858.24
IUPAC NameN-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide
SMILESCC(C)(C(=O)Nc1n[nH]c(-c2ccccc2)n1)S(=O)(=O)C1CCCC1.CC(C)(C(=O)Nc1n[nH]c(-c2ccccc2)n1)S(=O)(=O)CC1CCOCC1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)C2CCOCC2)on1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)CC2CC2)on1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)CC2CCC2)on1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)CC2CCOCC2)on1.CC(C)(C)c1nnc(NC(=O)C(C)(C)S(=O)(=O)C2CCCC2)s1.CC(C)CCS(=O)(=O)C(C)(C)C(=O)Nc1cc(C(C)(C)C)no1
InChIInChI=1S/C18H24N4O4S.C17H22N4O3S.C17H28N2O5S.C16H26N2O5S.C16H26N2O4S.C16H28N2O4S.C15H25N3O3S2.C15H24N2O4S/c1-18(2,27(24,25)12-13-8-10-26-11-9-13)16(23)20-17-19-15(21-22-17)14-6-4-3-5-7-14;1-17(2,25(23,24)13-10-6-7-11-13)15(22)19-16-18-14(20-21-16)12-8-4-3-5-9-12;1-16(2,3)13-10-14(24-19-13)18-15(20)17(4,5)25(21,22)11-12-6-8-23-9-7-12;1-15(2,3)12-10-13(23-18-12)17-14(19)16(4,5)24(20,21)11-6-8-22-9-7-11;1-15(2,3)12-9-13(22-18-12)17-14(19)16(4,5)23(20,21)10-11-7-6-8-11;1-11(2)8-9-23(20,21)16(6,7)14(19)17-13-10-12(18-22-13)15(3,4)5;1-14(2,3)12-17-18-13(22-12)16-11(19)15(4,5)23(20,21)10-8-6-7-9-10;1-14(2,3)11-8-12(21-17-11)16-13(18)15(4,5)22(19,20)9-10-6-7-10/h3-7,13H,8-12H2,1-2H3,(H2,19,20,21,22,23);3-5,8-9,13H,6-7,10-11H2,1-2H3,(H2,18,19,20,21,22);10,12H,6-9,11H2,1-5H3,(H,18,20);10-11H,6-9H2,1-5H3,(H,17,19);9,11H,6-8,10H2,1-5H3,(H,17,19);10-11H,8-9H2,1-7H3,(H,17,19);10H,6-9H2,1-5H3,(H,16,18,19);8,10H,6-7,9H2,1-5H3,(H,16,18)
InChIKeyOAZQMSSRHNWHKA-UHFFFAOYSA-N
XLogP20.87
TPSA772.68 Ų
H-Bond Donors10
H-Bond Acceptors44
Rotatable Bonds40
Heavy Atoms192
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002860.77
LogP ≤ 520.87
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1044

Analyze N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide?
The IUPAC name of N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide (CID 173123498) is N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide.
What is the SMILES notation for N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide?
The canonical SMILES for N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide is CC(C)(C(=O)Nc1n[nH]c(-c2ccccc2)n1)S(=O)(=O)C1CCCC1.CC(C)(C(=O)Nc1n[nH]c(-c2ccccc2)n1)S(=O)(=O)CC1CCOCC1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)C2CCOCC2)on1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)CC2CC2)on1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)CC2CCC2)on1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)CC2CCOCC2)on1.CC(C)(C)c1nnc(NC(=O)C(C)(C)S(=O)(=O)C2CCCC2)s1.CC(C)CCS(=O)(=O)C(C)(C)C(=O)Nc1cc(C(C)(C)C)no1.
What is the InChIKey of N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide?
The InChIKey is OAZQMSSRHNWHKA-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H24N4O4S.C17H22N4O3S.C17H28N2O5S.C16H26N2O5S.C16H26N2O4S.C16H28N2O4S.C15H25N3O3S2.C15H24N2O4S/c1-18(2,27(24,25)12-13-8-10-26-11-9-13)16(23)20-17-19-15(21-22-17)14-6-4-3-5-7-14;1-17(2,25(23,24)13-10-6-7-11-13)15(22)19-16-18-14(20-21-16)12-8-4-3-5-9-12;1-16(2,3)13-10-14(24-19-13)18-15(20)17(4,5)25(21,22)11-12-6-8-23-9-7-12;1-15(2,3)12-10-13(23-18-12)17-14(19)16(4,5)24(20,21)11-6-8-22-9-7-11;1-15(2,3)12-9-13(22-18-12)17-14(19)16(4,5)23(20,21)10-11-7-6-8-11;1-11(2)8-9-23(20,21)16(6,7)14(19)17-13-10-12(18-22-13)15(3,4)5;1-14(2,3)12-17-18-13(22-12)16-11(19)15(4,5)23(20,21)10-8-6-7-9-10;1-14(2,3)11-8-12(21-17-11)16-13(18)15(4,5)22(19,20)9-10-6-7-10/h3-7,13H,8-12H2,1-2H3,(H2,19,20,21,22,23);3-5,8-9,13H,6-7,10-11H2,1-2H3,(H2,18,19,20,21,22);10,12H,6-9,11H2,1-5H3,(H,18,20);10-11H,6-9H2,1-5H3,(H,17,19);9,11H,6-8,10H2,1-5H3,(H,17,19);10-11H,8-9H2,1-7H3,(H,17,19);10H,6-9H2,1-5H3,(H,16,18,19);8,10H,6-7,9H2,1-5H3,(H,16,18).
What are the key properties of N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide?
N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide has a molecular weight of 2860.77 g/mol, XLogP of 20.87, 40 rotatable bonds, 10 hydrogen bond donors, and 44 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclobutylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-(cyclopropylmethylsulfonyl)-2-methylpropanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(3-methylbutylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide;N-(3-tert-butyl-1,2-oxazol-5-yl)-2-methyl-2-(oxan-4-ylsulfonyl)propanamide;N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-cyclopentylsulfonyl-2-methylpropanamide;2-cyclopentylsulfonyl-2-methyl-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide;2-methyl-2-(oxan-4-ylmethylsulfonyl)-N-(5-phenyl-1H-1,2,4-triazol-3-yl)propanamide is sourced from PubChem (CID 173123498), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).